4//SEC Filing
MERRIMACK PHARMACEUTICALS INC 4
Accession 0001209191-17-020368
CIK 0001274792operating
Filed
Mar 12, 8:00 PM ET
Accepted
Mar 13, 9:04 PM ET
Size
8.8 KB
Accession
0001209191-17-020368
Insider Transaction Report
Form 4
PORTER MICHAEL E
Director
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2017-03-10−60,000→ 0 totalExercise: $2.69Exp: 2020-12-08→ Common Stock (60,000 underlying) - Exercise/Conversion
Stock Option (right to buy)
2017-03-10−25,000→ 0 totalExercise: $2.69Exp: 2020-10-14→ Common Stock (25,000 underlying) - Exercise/Conversion
Common Stock
2017-03-10$2.69/sh+85,000$228,650→ 839,448 total
Footnotes (1)
- [F1]This option is fully vested.
Documents
Issuer
MERRIMACK PHARMACEUTICALS INC
CIK 0001274792
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001274792
Filing Metadata
- Form type
- 4
- Filed
- Mar 12, 8:00 PM ET
- Accepted
- Mar 13, 9:04 PM ET
- Size
- 8.8 KB